Developing and innovating together
184
Results-
Business DevelopmentCreated on : - Last modified on :
-
Press ReleaseLicense and Commercialization agreement between Pierre Fabre and ValenzaBio on an anti-IGF-1R antibody for the development of a novel treatment in Thyroid Eye Disease (TED)Created on : - Last modified on :
-
Press ReleaseY-Biologics and Pierre Fabre confirms their research collaboration for the development of new immunotherapies in oncologyCreated on : - Last modified on :Daejeon (South Korea), Castres (France), March 29th, 2021 – The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre announce the conclusion of a strategic Research Collaboration & Optional License Agreement concerning several targets in the field of immuno-oncology.
-
Press Release1962-2022: THE PIERRE FABRE GROUP CELEBRATES ITS 60TH ANNIVERSARYCreated on : - Last modified on :Castres, May 23, 2022 - Founded on May 30, 1962 in Castres by a young pharmacist, an entrepreneur at heart and a botany enthusiast, the Pierre Fabre Group is preparing to celebrate its 60th anniversary. For six decades, without ever denying its Occitan roots, Pierre Fabre has become a world-class player in oncology, dermatology and dermo-cosmetics.
-
Press ReleasePierre Fabre becomes the first international manufacturing group to be awarded the “Outstanding” level of the Responsibility Europe label delivered by AFNOR CertificationCreated on : - Last modified on :Castres, September 28, 2022. The Pierre Fabre Group’s social and environmental responsibility policy has just been awarded the “Outstanding” level of the Responsibility Europe label from independent certification body AFNOR Certification. Pierre Fabre’s overall score of 788 points out of 1,000 means that the Group belongs to the top 1% of the 266 companies audited to-date by AFNOR Certification. It becomes the first international manufacturing group with more than 5,000 employees to obtain the “Outstanding” level of the label.
-
Our GovernanceCreated on : - Last modified on :
-
Our Key FiguresCreated on : - Last modified on :
-
Who We AreCreated on : - Last modified on :
-
Home PageCreated on : - Last modified on :
-
Press ReleaseRARE DISEASE DAY – February 28th, 2023Created on : - Last modified on :Pierre Fabre pursues its commitment against rare diseases in the pediatric, oncology and dermatology fields. The diseases are rare, but they impact a lot of people : nearly 300 million people are affected worldwide1.
We take care of life by designing and developing innovative solutions inspired by consumers and patients, and contributing to the well-being of everyone from health to beauty.